Remove topics minister-of-health
article thumbnail

Balancing Innovation: India’s Views for Pharmaceuticals in the Efta Trade Deal

IIPRD

vi] This is where governments use ‘compulsory licensing’ to ensure access to affordable drugs in public health emergencies and foster innovation, where patents and monopolies gained through it has prevailed. Here, developing a new medicine requires substantial investment which comes with a high degree of uncertainty. [iv]

article thumbnail

IP Rights, Access, and WHO’s Pandemic Accord

SpicyIP

The failures during the COVID pandemic were multifaceted, involving inadequate global coordination, underfunded health systems, and challenges in implementing measures effectively. Arnav is a second-year law student at West Bengal National University of Juridical Sciences, Kolkata.

IP 59
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

SpicyIP Weekly Review (July 26 – August 1)

SpicyIP

Topical Highlight. A Parliamentary Standing Committee Report that Challenges the Fine Balances Within the IP System. In a guest post , Dr. Arul George Scaria writes about the macro and structural issues with the recently released Parliamentary Standing Committee Report on IPR. The post focuses on three methodological flaws in the Report.

Reporting 116
article thumbnail

SpicyIP Weekly Review (February 05- February 11)

SpicyIP

Last week we published 9 posts on topics such as our comments on the proposed Trademarks (1st Amendment) Rules, the Madras High Court’s decision with respect to patentability of business methods, and Union Minister of State for Commerce’s response on ability of the current IPR regime to cater concerns arising out of AI generated work.

Trademark 103
article thumbnail

A Look Back at India’s Top IP Developments of 2021

SpicyIP

This year, we have divided these developments into three categories: a) Top 10 IP Judgments/Orders (Topicality/Impact). This year, we have divided these developments into three categories: a) Top 10 IP Judgments/Orders (Topicality/Impact). Top 10 Judgments/Orders [Topicality/Impact]. Image from here. H Lundbeck A/S v.

IP 143
article thumbnail

G7 Leaders Publish AI Code of Conduct: A Common Thread in the Patchwork of Emerging AI Regulations Globally?

LexBlog IP

The Statement was accompanied by the Hiroshima Process International Code of Conduct for Organizations Developing Advanced AI Systems (the “ Code of Conduct ”)[2] and the Hiroshima Process International Guiding Principles for Advanced AI Systems (the “ Guiding Principles ”).[3] For example, in the U.S.,